Showing 3 of 3 recruiting trials for “crigler-najjar-syndrome”
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
👨⚕️ Allen Yeoh, M.D, National University Hospital, Singapore📍 1 site📅 Started Apr 2021View details ↗
Gene Therapy for Severe Crigler Najjar Syndrome
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
👨⚕️ Zhenfeng Zhang, MD,PhD, Second Affiliated Hospital of Guangzhou Medical University📍 2 sites📅 Started Jul 2017View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →